Accès ouvert
2023
article
OpenAlex
Nina Kim, Joaquin J. Estrada, Isabella Chow, Aleksandrina Ruseva et autres
Purpose: To demonstrate a need for improved health insurance coverage for anti-obesity medications (AOMs) by comparing clinical and economic benefits of obesity treatments to covered medications for selected therapeutic areas. Methods: Using a grey literature search, we identified and prioritized therapeutic areas …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Nina Kim, T. Michelle Brown, Chakkarin Burudpakdee, Chisom Kanu et autres
INTRODUCTION: Discussions of weight-management strategies between patients and healthcare providers can yield positive outcomes for people with overweight or obesity. Nonetheless, people with overweight or obesity encounter communication challenges and other barriers to pursuing effective weight-management strategies with their healthcare providers. The …
us, no
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Nina Kim, Jessie J.J. Wang, Chakkarin Burudpakdee, Yan Song et autres
BACKGROUND: The rising prevalence and associated public health burden of obesity has led to advancements in pharmaceuticals for weight management. Semaglutide 2.4 mg, an anti-obesity medication (AOM) recently approved by the US Food and Drug Administration, has demonstrated clinically relevant weight loss …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
N Kim, J Estrada, I Chow, A Ruseva et autres
us
(code pays fourni par la source)
2022
article
OpenAlex
Chakkarin Burudpakdee
OBJECTIVES: To understand real-world implementation of the updated CDC HIV diagnostic testing algorithm. STUDY DESIGN: Retrospective database analysis. METHODS: Using data from Quest Diagnostics, we identified patients with at least 1 HIV-1/HIV-2 antibody differentiation test (BioRad Geenius HIV 1/2 Supplemental Assay [Geenius]) …
Accès ouvert
2022
article
OpenAlex
Landon W Trost, Huan Huang, Xu Han, Chakkarin Burudpakdee et autres
Collagenase clostridium histolyticum (CCH) is an injectable therapy targeting collagen present in penile plaques in Peyronie's disease (PD). Data comparing CCH to penile surgery are limited, and long-term therapeutic outcomes are unknown. This retrospective analysis used a US claims database (January 2014-June …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Robin K. Dore, Jenya Antonova, Chakkarin Burudpakdee, Lawrence Chang et autres
OBJECTIVE: Comorbidities in rheumatoid arthritis (RA) can influence treatment selection, impact treatment persistency, and increase health care costs. This study assessed the magnitude of comorbidity burden via epidemiology (incidence and prevalence) and associated costs of select comorbidities in RA patients: anemia, malignancy, …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Aimee M. Near, Chakkarin Burudpakdee, Shilpa Viswanathan, Shuchita Kaila
INTRODUCTION: In 2015, Boehringer Ingelheim (BI) created a support program for patients with idiopathic pulmonary fibrosis (IPF) treated with nintedanib, to help patients obtain their prescription, learn about their disease and medication, and provide support in the management of their IPF. The …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Landon W Trost, Huan Huang, Xu Han, Chakkarin Burudpakdee et autres
INTRODUCTION: Treatments for Peyronie's disease (PD) include surgical management and collagenase clostridium histolyticum (CCH). AIMS: To evaluate PD treatment trends after CCH approval and compare clinical outcomes in CCH- and surgery-treated cohorts. METHODS: Patients newly diagnosed with PD between January 2011 and …
us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Ileen Gilbert, Keiko Wada, Chakkarin Burudpakdee, Chirag Ghai et autres
Purpose: Budesonide/formoterol pressurized metered-dose inhaler (pMDI) was removed from a Medicare Part D formulary, and patients switched to fluticasone-based dry powder inhaler (DPI) therapies. This study describes the experience, satisfaction, and disease control among patients with asthma or chronic obstructive pulmonary disease …
us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
I Gilbert, K Wada, Chakkarin Burudpakdee, C Ghai et autres
Ileen Gilbert,1 Keiko Wada,2 Chakkarin Burudpakdee,2 Chirag Ghai,2 Laren Tan3 1AstraZeneca, Wilmington, DE, USA; 2IQVIA, Falls Church, VA, USA; 3Loma Linda University Health, Department of Medicine, Division of Pulmonary, Critical Care, Hyperbaric, Allergy and Sleep Medicine, Loma Linda, CA, USACorrespondence: Ileen Gilbert …
Accès ouvert
2020
erratum
OpenAlex
Shaum Kabadi, Aimee M. Near, Keiko Wada, Chakkarin Burudpakdee
us, gb
(code pays fourni par la source)